Aldeyra Therapeutics, Inc. (ALDX)

1.74 +0.02 (+1.16%) USD  |  NASDAQ  |  May 06, 16:00
1.79 +0.05 (+2.87%) Pre-Market: 08:22
More

Aldeyra Therapeutics SG&A Expense (TTM) : 9.602M for Dec. 31, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for ALDX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Alnylam Pharmaceuticals, Inc. 1.293B
Rhythm Pharmaceuticals, Inc. 155.85M
Pfizer Inc. 10.76B
AbbVie, Inc. 14.30B
Glaukos Corp. 354.02M